{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:29:15Z","timestamp":1786667355360,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"2023 Medical and Health Technology Innovation Research Program of Hengzhou City","award":["H20231201"],"award-info":[{"award-number":["H20231201"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) is characterized by pronounced intratumoral heterogeneity and multifocality, presenting ongoing challenges for early and precise diagnosis. In clinical practice, a substantial proportion of patients initially diagnosed with benign prostatic hyperplasia (BPH) are subsequently found to harbor latent PCa during follow-up. However, current prostate-specific antigen (PSA)-based screening lacks the specificity required to resolve this diagnostic overlap. This study aimed to develop and internally validate an interpretable machine learning (ML) model as an adjunct to PSA testing for identifying latent PCa in patients initially diagnosed with BPH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study utilized data from 1,071 patients to develop a machine learning framework aimed at identifying pre-existing occult PCa diagnosed at least 6 months after the initial BPH assessment. The cohort was partitioned into training (70%) and test (30%) subsets. Within the training set, Recursive Feature Elimination (RFE) was utilized to identify a concise biomarker signature. Six machine learning algorithms were evaluated: logistic regression (LR), random forest (RF), extreme gradient boosting (XGB), support vector machine (SVM), k-nearest neighbors (KNN), and multilayer perceptron (MLP). Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), Brier score, and decision curve analysis (DCA). Model interpretability was facilitated through SHapley Additive exPlanations (SHAP) and Locally Weighted Scatterplot Smoothing (LOWESS) analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A concise four-biomarker signature comprising total prostate-specific antigen (tPSA), lactate dehydrogenase (LDH), red blood cell count (RBC), and creatine kinase-MB (CK-MB) was identified. The MLP and LR models exhibited high diagnostic performance, with test AUROC values of 0.949 and 0.946, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This research developed and internally validated an interpretable machine learning framework designed to complement traditional PSA screening methodologies. The tool is intended exclusively for research purposes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12911-026-03623-w","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T16:44:17Z","timestamp":1780937057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and interpretability of a machine learning-derived model for the identification of latent prostate cancer in patients initially diagnosed with benign prostatic hyperplasia: a retrospective cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Sheng","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuansi","family":"Lao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zengfu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"8","key":"3623_CR1","doi-asserted-by":"publisher","first-page":"e031331","DOI":"10.1136\/bmjopen-2019-031331","volume":"9","author":"A Earnest","year":"2019","unstructured":"Earnest A, Evans SM, Sampurno F, Millar J. Forecasting annual incidence and mortality rate for prostate cancer in Australia until 2022 using autoregressive integrated moving average (ARIMA) models. BMJ Open. 2019;9(8):e031331.","journal-title":"BMJ Open"},{"issue":"2","key":"3623_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 2018;173(2):291\u2013e3046.","journal-title":"Cell"},{"key":"3623_CR3","doi-asserted-by":"publisher","unstructured":"Abida W, Armenia J, Gopalan A, Brennan R, Walsh M, Barron D, et al. Prospective genomic profiling of prostate cancer across disease states reveals germline and somatic alterations that may affect clinical decision making. JCO Precis Oncol. 2017;1:1-16. https:\/\/doi.org\/10.1200\/PO.17.00029.","DOI":"10.1200\/PO.17.00029"},{"issue":"14","key":"3623_CR4","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1002\/pros.23892","volume":"79","author":"T Wu","year":"2019","unstructured":"Wu T, Zhao J, Liu Z, Shen P, Zhang M, Sun G, et al. Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer? Prostate. 2019;79(14):1673\u201382.","journal-title":"Prostate"},{"issue":"1","key":"3623_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/bju.13676","volume":"120","author":"S Loeb","year":"2017","unstructured":"Loeb S, Shin SS, Broyles DL, Wei JT, Sanda M, Klee G, et al. Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer. BJU Int. 2017;120(1):61\u20138.","journal-title":"BJU Int"},{"issue":"2","key":"3623_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.euf.2016.07.007","volume":"4","author":"M Gayet","year":"2018","unstructured":"Gayet M, Mannaerts CK, Nieboer D, Beerlage HP, Wijkstra H, Mulders PFA, et al. Prediction of Prostate Cancer: External Validation of the ERSPC Risk Calculator in a Contemporary Dutch Clinical Cohort. Eur Urol Focus. 2018;4(2):228\u201334.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"3623_CR7","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12911-024-02751-5","volume":"24","author":"H Xu","year":"2024","unstructured":"Xu H, Peng X, Peng Z, Wang R, Zhou R, Fu L. Construction and SHAP interpretability analysis of a risk prediction model for feeding intolerance in preterm newborns based on machine learning. BMC Med Inf Decis Mak. 2024;24(1):342.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"42","key":"3623_CR8","doi-asserted-by":"publisher","first-page":"e45319","DOI":"10.1097\/MD.0000000000045319","volume":"104","author":"P Geng","year":"2025","unstructured":"Geng P, Feng W, Shi Z, Gao R, Gao Q, Jing Q, et al. Building a multi-model fusion prostate cancer risk prediction model based on clinical data and machine learning. Med (Baltim). 2025;104(42):e45319.","journal-title":"Med (Baltim)"},{"issue":"1","key":"3623_CR9","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao D, Vela I, Sboner A, Iaquinta PJ, Karthaus WR, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159(1):176\u201387.","journal-title":"Cell"},{"issue":"1","key":"3623_CR10","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41467-021-21300-6","volume":"12","author":"S Karkampouna","year":"2021","unstructured":"Karkampouna S, La Manna F, Benjak A, Kiener M, De Menna M, Zoni E, et al. Patient-derived xenografts and organoids model therapy response in prostate cancer. Nat Commun. 2021;12(1):1117.","journal-title":"Nat Commun"},{"issue":"9","key":"3623_CR11","doi-asserted-by":"publisher","first-page":"e0274569","DOI":"10.1371\/journal.pone.0274569","volume":"17","author":"MES Kiefer","year":"2022","unstructured":"Kiefer MES, Fritsch S, Bickenbach SJ, Schuppert J. A training strategy for hybrid models to break the curse of dimensionality. PLoS ONE. 2022;17(9):e0274569.","journal-title":"PLoS ONE"},{"issue":"1","key":"3623_CR12","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.1038\/s41598-024-55577-6","volume":"14","author":"ME Samadi","year":"2024","unstructured":"Samadi ME, Guzman-Maldonado J, Nikulina K, Mirzaieazar H, Sharafutdinov K, Fritsch SJ, et al. A hybrid modeling framework for generalizable and interpretable predictions of ICU mortality across multiple hospitals. Sci Rep. 2024;14(1):5725.","journal-title":"Sci Rep"},{"issue":"2","key":"3623_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1080\/13811118.2022.2064255","volume":"27","author":"BJH Yarborough","year":"2023","unstructured":"Yarborough BJH, Stumbo SP. A Stakeholder-Informed Ethical Framework to Guide Implementation of Suicide Risk Prediction Models Derived from Electronic Health Records. Arch Suicide Res. 2023;27(2):704\u201317.","journal-title":"Arch Suicide Res"},{"issue":"10","key":"3623_CR14","doi-asserted-by":"publisher","first-page":"100241","DOI":"10.1016\/j.modpat.2023.100241","volume":"36","author":"P Patel","year":"2023","unstructured":"Patel P, Harmon S, Iseman R, Ludkowski O, Auman H, Hawley S, et al. Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study. Mod Pathol. 2023;36(10):100241.","journal-title":"Mod Pathol"},{"issue":"2","key":"3623_CR15","first-page":"92","volume":"26","author":"JE McDunn","year":"2015","unstructured":"McDunn JE, Stirdivant SM, Ford LA, Wolfert RL. Metabolomics and its Application to the Development of Clinical Laboratory Tests for Prostate Cancer. Ejifcc. 2015;26(2):92\u2013104.","journal-title":"Ejifcc"},{"key":"3623_CR16","doi-asserted-by":"publisher","first-page":"e078276","DOI":"10.1136\/bmj-2023-078276","volume":"386","author":"O Efthimiou","year":"2024","unstructured":"Efthimiou O, Seo M, Chalkou K, Debray T, Egger M, Salanti G. Developing clinical prediction models: a step-by-step guide. BMJ. 2024;386:e078276.","journal-title":"BMJ"},{"issue":"1","key":"3623_CR17","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00345-024-04995-2","volume":"42","author":"J Huang","year":"2024","unstructured":"Huang J, He C, Xu P, Song B, Zhao H, Yin B, et al. Development and validation of a clinical-radiomics model for prediction of prostate cancer: a multicenter study. World J Urol. 2024;42(1):275.","journal-title":"World J Urol"},{"issue":"1","key":"3623_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/oxfordjournals.epirev.a000792","volume":"23","author":"AW Hsing","year":"2001","unstructured":"Hsing AW, Devesa SS. Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev. 2001;23(1):3\u201313.","journal-title":"Epidemiol Rev"},{"issue":"4","key":"3623_CR19","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/ije\/dyu192","volume":"44","author":"OO Aalen","year":"2015","unstructured":"Aalen OO, Valberg M, Grotmol T, Tretli S. Understanding variation in disease risk: the elusive concept of frailty. Int J Epidemiol. 2015;44(4):1408\u201321.","journal-title":"Int J Epidemiol"},{"issue":"10","key":"3623_CR20","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/pros.24537","volume":"83","author":"GS Dite","year":"2023","unstructured":"Dite GS, Spaeth E, Murphy NM, Allman R. Development and validation of a simple prostate cancer risk prediction model based on age, family history, and polygenic risk. Prostate. 2023;83(10):962\u20139.","journal-title":"Prostate"},{"issue":"5","key":"3623_CR21","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.euo.2018.09.008","volume":"2","author":"T Palsdottir","year":"2019","unstructured":"Palsdottir T, Nordstr\u00f6m T, Aly M, J\u00e4derling F, Clements M, Gr\u00f6nberg H, et al. A Unified Prostate Cancer Risk Prediction Model Combining the Stockholm3 Test and Magnetic Resonance Imaging. Eur Urol Oncol. 2019;2(5):490\u20136.","journal-title":"Eur Urol Oncol"},{"issue":"4","key":"3623_CR22","doi-asserted-by":"publisher","first-page":"525","DOI":"10.4103\/1008-682X.179857","volume":"18","author":"R Na","year":"2016","unstructured":"Na R, Ye D, Qi J, Liu F, Lin X, Helfand BT, et al. Race-specific genetic risk score is more accurate than nonrace-specific genetic risk score for predicting prostate cancer and high-grade diseases. Asian J Androl. 2016;18(4):525\u20139.","journal-title":"Asian J Androl"},{"issue":"4","key":"3623_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.eururo.2010.06.023","volume":"58","author":"V Cavadas","year":"2010","unstructured":"Cavadas V, Os\u00f3rio L, Sabell F, Teves F, Branco F, Silva-Ramos M. Prostate cancer prevention trial and European randomized study of screening for prostate cancer risk calculators: a performance comparison in a contemporary screened cohort. Eur Urol. 2010;58(4):551\u20138.","journal-title":"Eur Urol"},{"issue":"4","key":"3623_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s10334-022-01019-1","volume":"35","author":"A O\u2019Shea","year":"2022","unstructured":"O\u2019Shea A, Harisinghani M. PI-RADS: multiparametric MRI in prostate cancer. Magma. 2022;35(4):523\u201332.","journal-title":"Magma"},{"issue":"7","key":"3623_CR25","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/pros.21475","volume":"72","author":"DK Yoon","year":"2012","unstructured":"Yoon DK, Park JY, Yoon S, Park MS, Moon du G, Lee JG, et al. Can the prostate risk calculator based on Western population be applied to Asian. population? Prostate. 2012;72(7):721\u20139.","journal-title":"population? Prostate"},{"issue":"Suppl 1","key":"3623_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3109\/0284186X.2010.529824","volume":"50","author":"M Aly","year":"2011","unstructured":"Aly M, Wiklund F, Gr\u00f6nberg H. Early detection of prostate cancer with emphasis on genetic markers. Acta Oncol. 2011;50(Suppl 1):18\u201323.","journal-title":"Acta Oncol"},{"issue":"1","key":"3623_CR27","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/0272989X07312725","volume":"28","author":"EW Steyerberg","year":"2008","unstructured":"Steyerberg EW, Vickers AJ. Decision curve analysis: a discussion. Med Decis Mak. 2008;28(1):146\u20139.","journal-title":"Med Decis Mak"},{"issue":"3","key":"3623_CR28","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends Biochem Sci. 2016;41(3):211\u20138.","journal-title":"Trends Biochem Sci"},{"issue":"2","key":"3623_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2019.06.009","volume":"36","author":"W Su","year":"2019","unstructured":"Su W, Han HH, Wang Y, Zhang B, Zhou B, Cheng Y, et al. The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression. Cancer Cell. 2019;36(2):139\u2013e5510.","journal-title":"Cancer Cell"},{"issue":"1","key":"3623_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"11","key":"3623_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2174\/0113894501373936250609114913","volume":"26","author":"M Abdollahzadeh","year":"2025","unstructured":"Abdollahzadeh M, Ghodsi R, Taherzadeh Z, Hatamipour M. Targeting Creatine and Creatine Kinase in Cancer: Exploring Potential Therapeutic Strategies. Curr Drug Targets. 2025;26(11):739\u201356.","journal-title":"Curr Drug Targets"},{"issue":"8","key":"3623_CR32","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1007\/s00726-016-2217-0","volume":"48","author":"YB Yan","year":"2016","unstructured":"Yan YB. Creatine kinase in cell cycle regulation and cancer. Amino Acids. 2016;48(8):1775\u201384.","journal-title":"Amino Acids"},{"key":"3623_CR33","doi-asserted-by":"publisher","first-page":"e00336","DOI":"10.1016\/j.plabm.2023.e00336","volume":"37","author":"Y Li","year":"2023","unstructured":"Li Y, Chen Y, Shao B, Liu J, Hu R, Zhao F, et al. Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening. Pract Lab Med. 2023;37:e00336.","journal-title":"Pract Lab Med"},{"issue":"3","key":"3623_CR34","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.eururo.2020.11.021","volume":"79","author":"NK Jairath","year":"2021","unstructured":"Jairath NK, Dal Pra A, Vince R Jr., Dess RT, Jackson WC, Tosoian JJ, et al. A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer. Eur Urol. 2021;79(3):374\u201383.","journal-title":"Eur Urol"},{"issue":"1","key":"3623_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1186\/s12911-025-03224-z","volume":"25","author":"ES M","year":"2025","unstructured":"M ES, Nikulina K, Fritsch SJ, Schuppert A. GPT-4o and the quest for machine learning interpretability in ICU risk of death prediction. BMC Med Inf Decis Mak. 2025;25(1):373.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"6","key":"3623_CR36","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/ijc.29894","volume":"138","author":"CK Zhou","year":"2016","unstructured":"Zhou CK, Check DP, Lortet-Tieulent J, Laversanne M, Jemal A, Ferlay J, et al. Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. Int J Cancer. 2016;138(6):1388\u2013400.","journal-title":"Int J Cancer"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12911-026-03623-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03623-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12911-026-03623-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:47:54Z","timestamp":1786664874000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12911-026-03623-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3623"],"URL":"https:\/\/doi.org\/10.1186\/s12911-026-03623-w","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"8 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Hengzhou People's Hospital (Approval No. kj2023-006, valid until December 31, 2026). Written informed consent was obtained from all participants prior to their enrollment in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"316"}}